The role of antihistamines in chronic actinic dermatitis treatment
- Authors: Orlov E.V.1, Konnov P.E.1
-
Affiliations:
- Samara State Medical Universit
- Issue: Vol 92, No 1 (2016)
- Pages: 81-84
- Section: DRUG TREATMENT IN DERMATOVENEROLOGY
- Submitted: 24.08.2017
- Published: 24.02.2016
- URL: https://vestnikdv.ru/jour/article/view/214
- DOI: https://doi.org/10.25208/0042-4609-2016-92-1-81-84
- ID: 214
Cite item
Full Text
Abstract
Inveterate actinic dermatitis is an immunologically mediated photodermatosis characterized by itchy eczematous dermhelminthiasis exposed to sunlight. The disease proceeds in the same way as the atopic eczema or atopic dermatitis. The treatment of patients with inveterate actinic dermatitis is similar to the treatment of patients with atopic dermatitis and eczema. Administration of the modern antihistaminic preparation desloratadine (Aerius) in the treatment has a positive effect on the skin process relief and on some cellular and humoral immunity factors.
About the authors
E. V. Orlov
Samara State Medical Universit
Author for correspondence.
Email: noemail@neicon.ru
Россия
P. E. Konnov
Samara State Medical Universit
Email: Konnoff@yandex.ru
Россия
References
- Guschin I.S. Antigistaminnyie preparatyi. M: Almaz-Press 2000; 55. [Гущин И.С. Антигистаминные препараты. М: Алмаз-Пресс 2000; 55.]
- Pyitskiy V.I. i dr. Allergicheskie bolezni. M: Meditsina 1984; 270. [Пыцкий В.И. и др. Аллергические болезни. М: Медицина 1984; 270.]
- Skripkin Yu.K., Kubanova A.A. Rukovodstvo dlya vrachey. M: Meditsina 1995; 2: 28-44. [Скрипкин Ю.К., Кубанова А.А. Руководство для врачей. М: Медицина 1995; (2): 28-44.]
- Chuchalin A.G. Strategiya profilaktiki allergii i bronhialnoy astmyi. Allerg i respirat zabol 2001; 1 (2): 100-101. [Чучалин А.Г. Стратегия профилактики аллергии и бронхиальной астмы. Аллерг и респират забол 2001; 1 (2): 100-101.]
- Anthes J., Richard C., West R. et al. Functional characteristics of desloratadine and other anhistamines in human H1 receptjrs. Allergy 2000; 55 (63): 279. (Abstract 994).
- Bousquet J., van Canwenberge P., Khaltaev K. et al. Allergic rinitis and its impact on asthma (ARIA). Pocket guide. Jeneva: WHO 2001; 23.
- Genovese A., Patella V., De Crescenzo G. et al. Loratadine and desethoxycarbonyl- loratadine inhibit the immunological release of mediators from human Fc epsilon R1 cells. Clin Exp Fllergy 1997; 27: 559-567.
- Handley D., Magnetti A., Higgins A. Exp Opin Drags 1998; 7 (7): 1045-1054.
- Henz B. The pharmacological profile of desloratadine. Allergy 2000; 56 (65): 7-13.
- Hurst D.S., Venge P. The presense of eosinophil cationic protein in midlle ear effusion. Otolarygol. Head Neck Surg 1993; 108: 711-722.
- Lippert U. et al. Inhibition of cytokine secretion from human leukemic mast cellsand basophils by H1- and H2-receptors antagonists. Exp Dermatol 2000; 9: 118-124.
- Nayak A., Lorber R., Salman L. Decongestant effects of desloratadine in patients with seasonal allergic rhinitis. J Allergy Clin Immunol 2000; 105: 1: 1122.
- Saarien U.M., Kajosaari M. Breastfeeding as prophylaxis against atopic diasises: prospective follow-up study until 17 yeas. Lancet 1995; 346: 1065-1069.
- So Yeon Paek, MD, Henry W. Lim, MD. Cronic actinic dermatitis. Dermatol Clin 2014; 32: 355-361.
- Emily L. Forsyth and Tomas P. Millard. Diagnosis and Pharmacological Treatment of cronic actinic dermatitis in the Ederly. Terapy in practice Drugs aging 2010; 27 (6): 451-456.